Sarcosine
肌氨酸
Report date: 2022/09/02 20:00:31
NME
Base Information
Drug NameSarcosine
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMclean HospitalMerck & Co Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesMedical University Of LodzNational Health Research Institutes
Active IndicationsN/A
Inactive Indications